iBio, Inc. (IBIO) Operating Margin % [USD] 2018 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
iBio, Inc. quarterly/annual Operating Margin history and growth rate from 2018 to 2023.
  • iBio, Inc. Operating Margin for the quarter ending September 30, 2023 was -53.6 K %, a 2906% decline year-over-year.
  • iBio, Inc. annual Operating Margin for 2022 was -1.58 K %, a 20.1% decline from 2021.
  • iBio, Inc. annual Operating Margin for 2021 was -1.31 K %, a 53.5% decline from 2020.
  • iBio, Inc. annual Operating Margin for 2020 was -855 %, a 9.27% decline from 2019.
Operating Margin, Quarterly (% [USD])
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -53.6 K -51.8 K -2906% Jul 1, 2023 Sep 30, 2023
Q4 2022 -1.97 K +202 +9.31% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.78 K -346 -24% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.58 K -264 -20.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.21 K -388 -47.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.17 K -1.25 K -136% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.44 K -558 -63.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.31 K -457 -53.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -820 +332 +28.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -921 -70.2 -8.25% Oct 1, 2020 Dec 31, 2020
Q3 2020 -880 -126 -16.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -855 -72.5 -9.27% Apr 1, 2020 Jun 30, 2020
Q1 2020 -1.15 K +41.3 +3.46% Jan 1, 2020 Mar 31, 2020
Q4 2019 -851 +930 +52.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -754 +3.28 K +81.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -782 +2.42 K +75.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.19 K Jan 1, 2019 Mar 31, 2019
Q4 2018 -1.78 K Oct 1, 2018 Dec 31, 2018
Q3 2018 -4.04 K Jul 1, 2018 Sep 30, 2018
Q2 2018 -3.2 K Apr 1, 2018 Jun 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.